Ahmet Gulmez

Adana, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group.

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group.

Journal: BMC cancer

Published: June 04, 2026

Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study.

Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study.

Journal: Cancer investigation

Published: December 05, 2025

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.

Journal: BMC cancer

Published: November 30, 2025

Evaluation of the efficacy of regorafenib treatment by location and RAS mutation in metastatic colon cancer.

Evaluation of the efficacy of regorafenib treatment by location and RAS mutation in metastatic colon cancer.

Journal: Medicine

Published: June 30, 2025

Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study.

Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study.

Journal: Medicina (Kaunas, Lithuania)

Published: March 06, 2025

Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study.

Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study.

Journal: Molecular and clinical oncology

Published: December 17, 2024

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Journal: Current oncology (Toronto, Ont.)

Published: August 04, 2024

Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.

Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.

Journal: Journal of chemotherapy (Florence, Italy)

Published: March 18, 2024

The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.

The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.

Journal: Journal of chemotherapy (Florence, Italy)

Published: January 24, 2024

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Journal: BMC cancer

Published: January 23, 2024

Are depression and poor sleep quality a major problem in Turkish Women receiving chemotherapy for breast cancer?

Are depression and poor sleep quality a major problem in Turkish Women receiving chemotherapy for breast cancer?

Journal: Revista da Associacao Medica Brasileira (1992)

Published: November 04, 2023

Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy.

Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy.

Journal: Medicina (Kaunas, Lithuania)

Published: August 11, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026